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Abstract
Background: Betulinic acid (BA), a member of pentacyclic triterpenes has shown important biological activities like
anti-bacterial, anti-malarial, anti-inflammatory and most interestingly anticancer property. To overcome its poor
aqueous solubility and low bioavailability, structural modifications of its functional groups are made to generate
novel lead(s) having better efficacy and less toxicity than the parent compound. BA analogue, 2c was found most
potent inhibitor of colon cancer cell line, HT-29 cells with IC50 value 14.9 μM which is significantly lower than
standard drug 5-fluorouracil as well as parent compound, Betulinic acid. We have studied another mode of PCD,
autophagy which is one of the important constituent of cellular catabolic system as well as we also studied
proteasomal degradation pathway to investigate whole catabolic pathway after exploration of 2c on HT-29 cells.
Methods: Mechanism of autophagic cell death was studied using fluorescent dye like acridine orange (AO) and
monodansylcadaverin (MDC) staining by using fluorescence microscopy. Various autophagic protein expression
levels were determined by Western Blotting, qRT-PCR and Immunostaining. Confocal Laser Scanning Microscopy
(CLSM) was used to study the colocalization of various autophagic proteins. These were accompanied by formation
of autophagic vacuoles as revealed by FACS and transmission electron microscopy (TEM). Proteasomal degradation
pathway was studied by proteasome-Glo™ assay systems using luminometer.
Results: The formation of autophagic vacuoles in HT-29 cells after 2c treatment was determined by fluorescence
staining – confirming the occurrence of autophagy. In addition, 2c was found to alter expression levels of different
autophagic proteins like Beclin-1, Atg 5, Atg 7, Atg 5-Atg 12, LC3B and autophagic adapter protein, p62. Furthermore
we found the formation of autophagolysosome by colocalization of LAMP-1 with LC3B, LC3B with Lysosome, p62 with
lysosome. Finally, as proteasomal degradation pathway downregulated after 2c treatment colocalization of ubiquitin
with lysosome and LC3B with p62 was studied to confirm that protein degradation in autophagy induced HT-29 cells
follows autolysosomal pathway.
Conclusions: In summary, betulinic acid analogue, 2c was able to induce autophagy in HT-29 cells and as proteasomal
degradation pathway downregulated after 2c treatment so protein degradation in autophagy induced HT-29 cells
follows autolysosomal pathway.
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Background
Natural products serve an important role and are used as
starting point in drug discovery program. Thus, nature
has been a source of medicinal agents for thousands of
years and an impressive number of modern drugs have
been isolated from natural sources [1]. In fact, a majority
of anticancer and anti-infectious agents are of natural
origin [2, 3].
Despite the obvious benefits of chemo treatment, which
is an effective drug treatment designed to kill cancer cells
in individuals, there are several adverse side effects to this
form of treatment that should be considered in every can-
cer treatment strategy as they tend to have various thera-
peutic effects and patients may ultimately die due to
multiple organ failure. Therefore development of alterna-
tive potent therapeutic agents having minimal side effects
is of current interest [4].
Today, numerous natural compounds extracted from
plants source are reported to possess growth inhibitory
effects on various tumor cells. Many medicinal plants
have been found as potential sources of many pharma-
ceuticals possessing diversified biological activities [5]
and most of these bioactive compounds have negligible
toxicity. Thus, plants are the reservoirs of a large num-
ber of important organic compounds and they have
long been used traditionally as the sources of medicines
to cure or prevent diseases [6]. The medicinal proper-
ties of plants could be defined based on the antioxidant,
antimicrobial, antipyretic effects and others effects of
the phytochemicals present in them [7]. As compared to
synthetic compounds, natural compounds have more
structural diversity and novelty and many natural chemi-
cals are able to interact with proteins, and other biological
molecules. Also, it is more complex in structure than syn-
thetic molecules. This complexity allows for more select-
ive binding to targets.
One such natural compound is Betulinic acid (3β-hy-
droxy-lup-20(29)-en-28-oic acid), methanolic extract of
Dillenia indica fruits, a lupane class type, naturally
occurring pentacyclic triterpenoid. It has antiretroviral,
anti-malarial and anti-inflammatory properties, as well
as a more recently discovered potential as an anticancer
agent, by inhibition of topoisomerase [7].
Earlier report suggest that one characteristic feature of
betulinic acid’s cytotoxicity is its ability to trigger the mito-
chondrial pathway of apoptosis which causes cancer cell
death [8]. It is reported that betulinic acid induces apop-
tosis in tumor cells which is accompanied by caspase acti-
vation, mitochondrial membrane alterations and DNA
fragmentation [9]. Similarly, we had earlier reported that
betulinic acid analogue, 2c induced apoptosis is accom-
panied by ROS generatlion, phosphatidyl serine exposure
to outer membrane, chromatin condensation and DNA
fragmentation [10].
In the present endeavour, we targeted to study another
classical form of PCD, autophagy as drug-induced autoph-
agy is progressively reported as a cause to induce cell
death. At the same time we also considered that autophagy
is one of the important pathways for cell death processes.
Two major pathways accomplish regulated protein catabol-
ism in eukaryotic cells: the autophagy-lysosomal system
which involves the sequestration of plasmatic portions and
intracellular organelles into double-membrane vacuoles
called autophagosomes and the ubiquitin-proteasome sys-
tem, the primary route of degradation for thousands of
short-lived proteins play a crucial role in monitoring other
basic cellular processes, like normal protein turnover, pro-
tein quality control by degrading misfolded and damaged
proteins, metabolism, cell death, cell cycle control etc. [11].
Ubiquitin, a small globular protein containing 76 amino
acid residues is covalently attached as a degradation signal
to other proteins which are going to be degraded in an
ATP-dependent manner and these ubiquitinated proteins
are generally delivered to proteasomes. Recognition of ubi-
quitinylated proteins is mediated by p62/SQSMT1, the first
protein reported to have such an adaptor function. Besides,
p62 possesses a C-terminal ubiquitin-binding domain
(UBA) [12] by which it interacts with ubiquitin noncova-
lently and a short LIR (LC3-interacting region) sequence
responsible for LC3 interaction [13]. It is known that p62
is required for the clearance of ubiquitinylated proteins
and it may also deliver ubiquitinylated cargos to the prote-
asome besides autolysosomes but they are mainly degraded
by autophagy [14, 15] and thus plays essential roles for
their autophagic clearance [16, 17]. Activation of proteaso-
mal degradation pathway is usually inversely correlated
with autophagic degradation.
Generally, activation of autophagy refers to cellular sur-
vival strategy whereas its persistent activation may lead to
cell death [18]. In this study, we demonstrate some prom-
ising results obtained from a betulinic acid analogue, 2c in
HT-29 colon carcinoma cells. Interestingly, it induced au-
tophagy by activating Atg proteins, LC3 conversion and
autophagosome formation.
Our study shows that the analogue 2c has potent anti-
cancer activity in relation to HT-29 cell line (Scheme 1).
Methods
Antibodies and reagents
Pen strep, RPMI 1640, DMEM, Heat inactivated Fetal
Bovine Serum (FBS), Lyso Tracker® Red DND-99 were
purchased from Invitrogen (Carlsbad, CA, USA). The
antibodies against β-Actin, Alkaline phosphatase/ Horse-
radish peroxidase conjugated secondary antibodies and
enhanced chemiluminescence kit were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). The
antibodies against Beclin-1, LC3, Atg 3, Atg 5, Atg 7,
Atg5-Atg 12, p62, LAMP-1, Ubiquitin were purchased
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from Cell Signaling Technology (Inc. Beverly, MA, USA).
Rapamycin was procured from Enzo Life Sciences (Farm-
ingdale, NY) as part of the Cyto-ID® Autophagy Detection
Kit. Alexa Fluor-633 and Alexa Fluor-488 were obtained
from Life Technologies (Carlsbad, CA, USA). Z-Val-Ala-
DL-Asp (methoxy)-fluoromethylketone (Z-VAD-FMK) was
obtained from BD Biosciences (San Jose, CA, USA). All
other chemicals were obtained from Sigma-Aldrich (St.
Louis, Missouri, USA).
Cell lines
HT-29-colon carcinoma (an adherent cancer cell line)
and HCT-15-Human colon adenocarcinoma (an adher-
ent cancer cell line) were obtained from National Centre
for Cell Sciences, Pune, India and maintained in RPMI-
1640 medium. The media were supplemented with 10 %
FBS and antibiotics (50 IU/ml penicillin G and 50 μg/ml
streptomycin). The cells were incubated at 37 °C in a
humidified incubator containing 5 % CO2 and subcul-
tured every 72 h using an inoculum of 5 × 105 cells/ml.
Cell viability (>95 %) was confirmed by trypan blue
exclusion.
Materials
3-(4,5-Dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium
bromide (MTT) was purchased from USB Corporation
(USA). Pen strep, RPMI 1640, High Glucose DMEM, and
Heat inactivated Fetal Bovine Serum (FBS), 5,5′,6,6′-tetra-
chloro-1,1′,3,3′- tetraethyl benzimidazolyl carbocyanine
iodide (JC-1), and 5-(and-6)-chloromethyl-2′,7′-dichloro
dihydrofluorescein diacetate (CM-H2DCFDA) were ob-
tained from Invitrogen (Carlsbad, CA, USA). Caspase-3,
Caspase-8, Caspase-9 colorimetric assay kits were pro-
cured from Biovision (Milpitas, CA, USA). The antibodies
against Bcl2, Bcl-xl, Bax, Bad, β-Actin, and PARP, Alkaline
phosphatase/Horseradish peroxidase conjugated second-
ary antibodies, and enhanced chemiluminescence kit were
purchased from Santa Cruz Biotechnology (Santa Cruz,
CA, USA).
Cell viability assay
The cytotoxic activity of 2c dissolved in DMSO (final
DMSO concentration <0.1 %) was assessed in HCT-15
using MTT assay. At first, cells (1.25–2.5 × 104 cells/
100 μl of RPMI 1640 or high glucose DMEM medium/
well) were cultured in 96-well tissue culture plates
followed by treatment with betulinic acid or its deriva-
tives dissolved in DMSO (using 0–50 μM concentration)
for 48 h at 37 °C, 5 % CO2. Thereafter, cell viability was
measured by adding 20 μl MTT (5 mg/ml in PBS) and in-
cubated for 4 h at 37 °C. Subsequently, 100 μl DMSO was
added to each well, resultant optical densities were mea-
sured at 540 nm in an ELISA Reader (BIO RAD, CA,
USA). The specific absorbance that represented formazan
production was calculated by subtraction of background
absorbance from total absorbance. The mean percentage
viability was calculated as follows:
Mean specific absorbance of treated cells
Mean specific absorbance of untreated cells
 100
The results were expressed as IC50 values which were
enumerated by graphical extrapolation using Graph Pad
Prism software (version 5, Graph Pad Prism software
Inc, San Diego, CA, USA). Each experiment was per-
formed at least three times and in duplicate.
Autophagy flux measurement
The method is based on Cyto-ID staining of autophagic
compartments (pre-autophagosomes, autophagosomes, and
autophagolysosomes) in live cells using Cyto-ID® Autoph-
agy Detection Kit. Autophagic compartments are deter-
mined as intermediate constituents of a dynamic lysosomal
degradation process and their intracellular abundance at a
particular time point is a function of the established
equilibrium between their generation and degradation.
Autophagic flux established the discrimination between
early induction of autophagosome formation and late
inhibition of autophagosome maturation results in an
ultimate increase in autophagosomal presence. Autoph-
agy was measured by staining autolysosomes and autopha-
gic compartments with the fluorescent probe Cyto-ID®
Green (Enzo Life Sciences, Farmingdale, NY) as recom-
mended by manufacturer. In Cyto-ID assay the specific dye
selectively stains autophagic compartments and therefore
allows determination of autophagic flux as accumulation of
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Scheme 1 Betulinic acid (1) and its designed analogue, 2c (2)
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stained compartments. Samples were then analyzed in the
green (FL1) channel of the FACS Caliber flow cytometer.
Briefly, HT-29 cells (105 to 106cells/ml) were treated with
analogue 2c (IC50; 14.9 μM) and positive control rapamycin
(1–5 μmol/L; 24 h) followed by washed with PBS. Cyto-ID
Green containing indicator was added to the cell culture
free medium, containing 5 % FBS. Cyto-ID Green concen-
tration contains 1 μl of Cyto-ID Green Detection Reagent
in 1 ml cell culture medium. It was then mixed well and
incubated for 30 min under standard tissue culture condi-
tions at 37 °C, 5 % CO2 in the dark. At the end of staining
procedure, the Cyto-ID containing medium was washed
with PBS. Then trypsinization was done and after washing
cells were resuspended in ice cold PBS and staining was
performed. Autophagy was measured by percent autopha-
gosome formation [19].
Acidic vesicular organelles detection
A basic evidence of autophagy induced cells is gradual for-
mation of Acidic vesicular organelles (AVO) [20]. Acridine
orange, a weak base that traverses freely across biological
membranes was used to stain AVOs in autophagic cells.
When there is no appearance of AVO, AO remains in an
uncharged state which shows green fluorescence. 2c
treated (IC50; 14.9 μM; 0–48 h) and control HT-29 cells
(2.5 × 105/ml) were washed in PBS and incubated with
AO (1 μg/ml) for 15 min at 25 °C [21]. Cells were again
washed with PBS. AVO formation was observed using
fluorescence microscope at an excitation of 488 nm and
emission of 530 and 650 nm.
Monodansylcadaverine (MDC) staining
Autophagic vacuoles were detected with Monodansylca-
daverine (MDC), a fluorescent compound which is in-
corporated in multilamellar bodies by two ways i.e. ion
trapping mechanism and interaction with membrane
lipids, used as a probe for detection of autophagic vacu-
oles (which are part of the lysosomal compartment) in
cultured cells.
Briefly, after treatment with analogue 2c (IC50; 14.9 μM)
HT-29 cells were treated with PBS and then incubated
with 0.05 mM of MDC (prepared in hot methanol) at
room temperature for 1 h. After incubation, the cells were
again washed three times with PBS and immediately ana-
lyzed by fluorescence microscopy (Olympus IX70) under
40× magnification using an excitation filter of 360 nm and
an emission filter of 525 nm [22].
Effect of 3-MA on 2c induced cytotoxicity
To study the effect of autophagy inhibitor 3-MA in 2c
induced cytotoxicity, HT-29 cells (2.5 × 104/100 μl of
RPMI 1640 medium / well) were pre-incubated with 3-
MA (10 mM) for 4 h before the addition of IC50 concen-
tration of 2c for 48 h at 37 °C, 5 % CO2. Thereafter,
20 μl MTT (5 mg/ml in PBS) was added and subjected
to measure cell viability after incubation for 4 h at 37 °C.
Subsequently, 100 μl DMSO was added to each well, re-
sultant optical densities were measured at 540 nm in an
ELISA Reader (BIO RAD, CA, USA). The specific ab-
sorbance that represented formazan production was cal-
culated by subtraction of background absorbance from
total absorbance. The mean percentage viability was cal-
culated as follows:
Mean specific absorbance of treated cells
Mean specific absorbance of untreated cells
 100
The results were determined as IC50 values which
were enumerated by graphical extrapolation using Graph
Pad Prism software (version 5, Graph Pad Prism soft-
ware Inc, San Diego, CA, USA). Each experiment was
performed at least three times and in duplicate.
Western blotting analysis
Control and 2c treated (IC50; 14.9 μM; 0–48 h) cells were
lysed in lysis buffer (50 mM Tris–HCl, pH 7.4, 150 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 1 μg/ml protease in-
hibitor cocktail, 5 mM PMSF and 1 mM DTT containing
1 % Triton X-100), sonicated and centrifuged for 10 min
at 4 °C at 10,000 × g and protein concentration estimated.
Electrophoretic separations (50 μg protein/ lane) were car-
ried out on 10 % SDS-polyacrylamide gel electrophoresis
and electrotransferred onto a PVDF membrane. Blots
were blocked for 1 h at 37 °C in 20 mM Tris-HCl, pH 7.4,
150 mM NaCl, 0.02 % Tween 20 (TBST) containing 5 %
skimmed milk and probed using 1:2000 dilution of appro-
priate antibodies (β-Actin, Beclin-1, Atg 3, Atg 5, Atg 7,
Atg 5–12, p62) by incubating overnight at 4 °C. The
membranes were washed thrice with TBST, incubated
with alkaline phosphatise / Horseradish peroxidase
conjugated secondary antibody and the bands visualized
using a 5-bromo-4-chloro-3-indolyl phosphate / nitro
blue tetrazolium substrate or enhanced chemilumines-
cence kit. For further quantification of protein bands
their Densitometric analysis was performed using the
software Image J as required. To study the effects of
various autophagic inhibitors, whole cell lysates were
prepared from control and 2c treated [(14.9 μM; 0,
48 h) Bafilomycin A1 (50 nM), E64d (10 μg/ml) with
pepstatin A (10 μg/ml), Chloroquine (5 μM)] HT-29
cells, protein concentration estimated and western blot-
ting analysis was done as described above.
Quantitative real-time PCR
Total RNAs, from the HT-29 cell line treated with
analogue 2c and respective control were isolated using
the Trizol method, purified and treated with DNase I.
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Briefly, 1 μg of total RNA from each sample was reverse
transcribed using the random hexamar primer in a 20 μl
reaction mixture. Each RNA sample was mixed with
400 ng of oligo-(dT)-P3 primer and incubated at 70 °C
for 10 min. The mix (10 μl) was quickly chilled on ice
and then mixed with equal volume of a mixture of 2×
reverse transcriptase buffer, 8 mM dNTPs (with dTT),
20 U RNase inhibitor and 50 U MultiScribe™ reverse
transcriptase (High capacity cDNA Reverse Transcrip-
tion kit, Applied Biosystems) and reverse transcribed at
42 °C for 60 min followed by inactivation at 70 °C for
10 min. The mRNA expression was determined by
quantitative PCR (qRT-PCR) on ABI 7000 PCR platform.
For this assay, 100 ng of cDNA was used in a 10 μl reac-
tion mixture with SYBR® Green PCR Master Mix (Ap-
plied Biosystems) and 25 ng of both forward and reverse
primers. Conditions for quantitative PCR was 94 °C for
5 min, 40 cycles of 94 °C for 30 s, 55 °C for 30 s, and
72 °C for 30 s [23]. All samples were amplified in dupli-
cate, and every experiment was repeated independently
at least two times. Relative gene expression was deter-
mined using the 2−ΔΔCT method, with GAPDH as the
internal control.
The following primers were used:
Transmission electron microscopy
Detecting the presence of autophagic vesicles by using
transmission electron microscopy (TEM) is the most
sensitive and gold standard technique to monitor
autophagy. Control and analogue 2c treated (14.9 μM;
0–48 h) HT-29 cells (2.5 × 105/ml) were fixed in 2.5 %
glutaraldehyde and 2 % paraformaldehyde in 0.1 M
phosphate buffer (pH 7.4) for 1 h at 4 °C. After rinsing
in PBS, cells were post fixed in osmium tetroxide (1 %)
for 2 h, dehydrated in graded acetone and embedded
in araldite CY212. Semi thin sections were cut, stained
with 0.5 % toluidine blue (5 min) and examined under
a light microscope (Olympus, 60 ×). Ultrathin sections
were stained with 2 % uranyl acetate and Reynold’s
lead citrate, and observed with a transmission electron
microscope (Technai G2) [24].
Proteasomal degradation assay
The Proteasome-Glo™ Cell-Based Assay are homoge-
neous, luminescent assays that individually measure the
chymotrypsin-like, trypsin-like or caspase like protease
activity associated with the proteasome complex in cul-
tured cells. The 26S proteasome is a 2.5 MDa multipro-
tein complex found both in the nucleus and cytosol of
all eukaryotic cells and is comprised of a single 20S core
particle and 19S regulatory particles at one or both ends
[25]. Three major protealytic activities as chymotrypsin-
like, trypsin-like and post-glutamyl peptide hydrolytic or
caspase-like were determined by proteasome-Glo™ assay
systems (Promega). Together these three activities are re-
sponsible for much of the protein degradation required to
maintain cellular homeostasis including degradation of crit-
ical cell-cycle proteins, tumor suppressors, transcription
factors, inhibitory proteins and damaged cellular proteins.
In brief, after treatment with 2c for 12, 24 and 48 h
HT-29 cells were removed from T-75 cm2 flask using
minimal (0.5–1.0 ml) amount of trypsin to flask surface
and incubated just until cells detached. Then complete
medium (10 % FBS) was added to cell suspension. After
two additional washing with complete medium, 10,000
cells per well were plated in 96-well plate.
Proteasome-Glo™ Cell-Based Reagent was prepared be-
fore beginning the assay according to Manufacturer’s in-
struction. 100 μl of Proteasome-Glo™ Cell-Based Reagent
was added to each 100 μl of sample and appropriate con-
trols as needed. Then the plate was covered using a plate
sealer. The contents of the wells were mixed at 700 rpm
for 2 mins using a plate shaker and incubated at room
temperature for a minimum period of 10 min. The lumi-
nescence of each sample was measured in a plate-reading
luminometer. Proteasomal activities were normalized by
total protein concentration.
Laser scanning confocal microscopy
The autophagy regulated proteins namely LC3B, Beclin I,
Atg 5, Atg 7, and adaptor protein P62 in the cytosol of au-
tophagic cells and their co localization in autophagic path-
way were analysed using confocal microscopy [26]. In
brief, HT-29 cells were grown on cover slips. After treat-
ment, cells were washed thrice with PBS. Then cells were
fixed with 4 % paraformaldehyde for 15 min followed by
permeabilized with 0.4 % Triton X-100 for 15 min at room
temperature. After blocking with BSA for 1 h, cells were
incubated overnight with primary antibodies of Beclin 1,
Atg 5, Atg 7, LC3B, p62, Ubiquitin, LAMP-1 diluted in
DPBS with 1 % BSA and 0.1 % Tween 20. Then cells were
washed thrice with PBS and incubated with fluorescent
tagged secondary antibodies atleast for 2 h. Alexa Fluor-
633 and Alexa Fluor-488 fluorescent conjugated second-
ary antibodies were used. LysoTracker Red DND-99 was
used to stain lysosomes in HT-29 cells. After rinsing in
Serial Primer Name Sequence (5′—3′)
1 GAPDH F HM CTCTGCTCCTCCTGTTCGAC
2 GAPDHR HM GTTAAAAGCAGCCCTGGTGA
3 Beclin1 F HM TAGACCAGCTGGACACTC
4 Beclin1 R HM CTTGCGGTTCTTTTCCAC
5 LC3B F M ACGGCGCTTGCAGCTCAATG
6 LC3B R M CGAGGCATAAACCATGTAC
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PBS 3 times, cells were finally counterstained with 1 mg/
ml of 4,6-diamidino-2-phenylindole (DAPI) to visualize
the nucleus for 5 mins and again washed with PBS for
three times. Fluorescence signals were captured using
laser scanning confocal microscope (Leica TCS SP2 Sys-
tem Leica Microsystem, Heidelberg, Germany, using
100×). At least 20 randomly selected microscopic fields
were observed per sample.
Statistical analysis
The statistically significant differences between control
and drug-treated cells were calculated using one way
ANOVA. Multiple comparisons were made between dif-
ferent treatments (analysis of variance) using Graph Pad
Prism Software (version 5, GraphPad Software Inc, San
Diego, CA, USA). All the experiments were carried out
in triplicate and values were reported as mean ± SD. Stu-
dent’s t test was used for determining statistical signifi-
cance (P <0.05). Software Origin 8.5, Image J were used
for preparation of different bar diagrammatic representa-
tions and measurement of intensities of images, blots
respectively.
Results
Cytotoxic activity of Betulinic Acid analogue, 2c on HCT-15
The cytotoxic activity of betulinic acid analogue, 2c was
studied using MTT assay on HCT-15. We assessed the
effects of different concentrations (0–50 μM) of 2c for
48 h. As in our previous study, 2c deciphering highest
cytotoxicity to HT-29 cells, anticancer activity of 2c was
also measured against another Human colon adenocar-
cinoma, HCT-15 cell line and interestingly IC50 value
was found 21.6 ± 1.3 μM. Finally, as 2c deciphering low-
est IC50 against HT-29, its role as an inducer of autoph-
agy was investigated only in HT-29 cell line.
Autophagy flux detection: % autophagosome formation
Authophagy induction can be examined by another
established method where a Cyto-ID Green dye was se-
lectively used to label autophagosomes and then the
presence of autophagosome in HT-29 cells was analysed
by flow cytometry. Autophagosomes were stained with
the Cyto-ID autophagy detection kit as described in ma-
terials and method. Cyto-ID Green dye was used to se-
lectively label autophagosome and the percentage of
Cyto-ID-positive cells correlates with the number of
autophagosome so we measured the percentage of Cyto-
ID-positive cells by flow cytometry with respect to dif-
ferent time period of incubation with the lead analogue,
2c. As shown in Fig. 1, the Flow cytometry analysis
clearly reveals that 2c treatment in HT-29 cells increased
the number of autophagosomes in a dose dependant
manner (12, 24 and 48 h) as compared to control indi-
cating 2c induces autophagy in HT-29 cells. The cells
were also treated with rapamycin (positive control) for
24 h and we found an increased percentage of Cyto-ID-
positive cells as compared to control suggesting that rapa-
mycin, an established inducer of autophagy also causes
increased percentage of Cyto-ID-positive cells.
2c induces AVO formation
Acidic vesicular organelles (AVO) formation js a well
established feature of autophagic cells [27]. Acridine Or-
ange (AO) is a lysotropic dye that accumulates in acidic
organelles in a pH-dependent manner. At neutral pH, Ac-
ridine Orange is a hydrophobic green fluorescent mol-
ecule. Within acidic vesicles, Acridine Orange becomes
protonated and trapped within the organelles. Protonated
Acridine Orange forms aggregates that emits bright red
fluorescence. We visualized the effect of betulinic acid
analogue 2c on AVO generation in HT-29 cells after its
staining with the lysosomotropic agent Acridine orange by
fluorescence microscopy as described in materials and
methods. As control cells do not contain any AVO, they
only displayed green fluorescence without any red fluore-
sorescence. When HT-29 cells were treated with 2c for
different time periods gradual increase of red fluorescence
was observed in a time dependent manner. Our data
reveals maximum red fluorescence observed after 48 h of
treatment indicating maximum number of AVO forma-
tion (Fig. 2).
Labeling of autophagic vacuoles with
monodansylcadaverine (MDC)
We next assessed whether analogue 2c induced autophagy
in HT-29 cells. Earlier reports suggests that MDC accu-
mulate in mature autophagic vacuoles such as autophago-
lysomes but not in the early endosomes compartments
[28]. Furthermore, autophagic vacuoles stained by MDC
appear as distinct dot like structure which is distributed in
the cytoplasm. MDC accumulation in autophagic vacuoles
is due to a combination of ion trapping and specific inter-
actions with vacuole membrane lipids. We studied the
incorporation of MDC stain in 2c treated HT-29 cells for
different duration of time (12, 24 and 48 h) by fluores-
cence microscopy. As shown in Fig. 3 MDC labeled vacu-
oles were scarcely detected in control cells, whereas the
cells which were treated with 2c, clearly showed numerous
MDC labeled fluorescent vacuoles with an increasing
intensity with respect to different time intervals indicating
that 2c treatment in HT-29 cells induced the formation of
the MDC labeled autophagic vacuoles.
2c causes alteration in autophagic proteins level
Atg proteins are fundamental proteins engaged in au-
tophagic pathway from initiation to maturation step and
play crucial role in autophagosome formation [29].
Beclin 1, the mammalian orthologue of yeast Atg 6, is a
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key regulatory protein in autophagic pathway. Bcl-2 fam-
ily proteins interact with Beclin1, inhibiting it through
binding with its BH3 domain and ultimately causes inhib-
ition of autophagy. Therefore, up regulation of Beclin1
family of protein with Atg proteins is another indicator of
autophagy. We studied the expression level of different
autophagic proteins by western blotting as described in
materials and methods. The expression levels of the Beclin
1, Atg 5, Atg 3, Atg 7, Atg 5-Atg 12 proteins were in-
creased and p62 level was decreased with analogue 2c
treatment (Fig. 4). Beclin 1 is required for initiating the
formation of autophagic vacuoles [30].
2c induces conversion of LC3
Recent investigations suggest that there are two forms of
LC3 protein LC3A and LC3B [31]. LC3A is cytoplasmic
form and is processed into LC3B which is autophagsome
membrane bound. Hence the amount of LC3B is corre-
lated with the extent of autophagosome formation. In our
study after treatment with analogue 2c for 12, 24 and 48 h
in HT-29 cells, the expression level of LC3A (18 kDa) and
LC3B (16 kDa) was investigated. Western blot displayed
gradual appearance of LC3B after 12, 24 and 48 h treat-
ment with respect to control (Fig. 5a). All protein expres-
sion levels confirm occurrence of autophagy. We further
Fig. 1 Autophagy Flux Measurement. HT-29 cells were treated with 2c for different time intervals (12, 24, 48 h) and one set with Rapamycin
(positive control) for 24 h only. Autophagy was measured by staining autophagosomes and autophagic compartments with the fluorescent
probe Cyto-ID® Green. a Control cells (b) positive Control and 2c treated HT-29 cells of (c) 12 h, (d) 24 h, (e) 48 h were stained and analyzed
in the green (FL1) channel of the FACS Caliber flow cytometer. f The graphical representation of autophagosome formation shown increasing
percentage of autophagosomes with respect to control cells according to the different time periods. This indicates increase in autophagy flux
formation in a time dependent manner. The figures are representative profile of at least three experiments
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Fig. 2 Formation of AVO. Control and 2c (14.9 μM; 0–48 h) treated HT-29 cells (2.5 × 105/ml) were stained with acridine orange (1 μg/ml) for 15 min
and AVO formation was measured using fluorescence microscope (60×)
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confirm this data with densitometric analysis which
demonstrated that level of LC3B/ LC3A protein rela-
tive to β-Actin increased significantly after 24 and 48 h
of 2c treatment (***p <0.001) with respect to control
(Fig. 5b).
Effects of various autophagic inhibitors on 2c induced
autophagy in HT-29 Cells
3-methyladenine (3-MA) interferes with autophagy initi-
ation by blocking Class III PI3K, an activator of autophagy
which plays a crucial role in the early step of autophago-
some formation i.e. responsible for autophagosome bio-
genesis in mammalian cells [32]. So, we were interested to
find out the role and contribution of 2c in autophagy in-
duced cell death. HT-29 cells were pretreated with 3-MA
(10 mM; 4 h), which blocks autophagy initiation and then
incubated with IC50 concentration of 2c for 48 h. 3-MA
significantly attenuated 2c induced cytotoxicity in HT-29
cells (Fig. 6). Bafilomycin A1, chloroquine and pepstatin
A+E64d are used to block autophagic progression by
impairing lysosomes. Monitoring LC3B conversion by
Western blot analysis in the presence of different lyso-
somal degradation inhibitors, such as bafilomycin A1,
chloroquine and pepstatin A+E64d [33], is a hallmark
experiment to detect progression of autophagic flux. It
is reported that when autophagic flux is induced, the
level of LC3B is increased in the presence of a lyso-
somal degradation inhibitor as the degradation of
LC3B through autolysosomal compartment will no
longer possible [34]. The conversion of LC3B signifi-
cantly increased in presence of each lysosomal degrad-
ation inhibitor after 48 h of treatment with 2c (Fig. 7).
2c causes alteration in mRNA expression level of key
autophagic proteins
Upregulation of mRNA expression of specific autophagic
proteins, induce autophagy. In this experiment, RNAs
were isolated from 2c treated HT-29 cells and the mRNA
expression levels of Beclin1 and LC3B were measured by
quantitative real-time PCR as described in materials
and methods. The cells were treated with analogue 2c
(IC50; 14.9 μM) for different time intervals (0–48 h)
then Beclin1 and LC3B expression relative to GAPDH
were determined by real-time PCR [35]. As shown in
Fig. 8, incubation with 2c increased the relative expres-
sion of Beclin1 and LC3B mRNA in HT-29 cell lines ac-
cording to the various time periods.
Fig. 3 2c induced vacuolization and formation of MDC-labeled vesicles in HT-29 cells. Cells were incubated in RPMI 1640 medium. After 2c treatment
with indicated time intervals, both treated and control cells (0 h) were incubated with MDC at 0.05 mM for 10 min at 37 °C followed by washing with
PBS (four times) and immediately analyzed under fluorescence microscopy where the nature of the vacuoles was confirmed to be authophagic (40×
magnification) with increasing intensity with respect to different time periods
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Quantification of autophagic vacuoles using TEM
Quantification of double-membrane vacuoles in autoph-
agic cells using TEM is a gold standard method to con-
firm occurance of autophagy. We have already showed
by light microscope that 2c treatment in HT-29 cells
(48 h) causes formation of cytoplasmic vacuoles and we
further confirm this result using transmission electron
microscopy, which demonstrated that control cells do
not contain any vacuoles while ultrastructure of 2c
treated (12, 24 and 48 h) cells showed presence of large
vacuoles (Fig. 9). These double membraned vacuoles ul-
timately fused with lysosomes resulting in the formation
of autolysosomes.
2c causes declination of proteasome degradation
pathway
Extensive evidence has shown that there is a connec-
tion between the two protein degradation pathway
namely ubiquitin proteasome system (UPS) and autoph-
agy. Autophagy complements the UPS for the degradation
of polyubiquinated proteins [36]. Evidences suggest that
activation of proteasomal degradation pathway is inversely
proportional to the activation of autophagic pathway. In-
hibition of the proteasome causes induction of autophagy.
The proteasome has three distinct ATPase-independent
protealytic activities, namely, caspase-like, trypsin-like and
chymotrypsin-like activities, which can be attributed to
the β1, β2 and β5 subunits respectively, within the consti-
tutive proteasome of the 20S core barrel-like structure of
the proteasome that has two outer heptameric rings of α
subunits and two inner heptameric rings of β subunits in
mammalian cells. In this experiment, the caspase-like,
trypsin like and chymotrypsin-like activities of the pro-
teasome were assayed by a chemiluminescence-based
method. The induction of autophagy by 2c treatment
reduced all three subtypes of proteasomal protealytic
activities in HT-29 cells (Fig. 10). From our data, it is
clearly visible that downregulation of trypsin-like,
chymotrypsin-like and caspase-like occurs with respect
to control at various time intervals (12, 24 and 48 h).
Immunostaining of different autophagic proteins and
their colocalization
Western Blot analysis of autophagic proteins prompted
us for further investigation to finally confirm all the hall-
mark phenomenon of autophagic pathway. Autophagy is
mainly monitored by Atg family of proteins and LC3B
expression considered as a convincing marker of autoph-
agy can be detected by confocal microscopy.
Fig. 4 Expression of Autophagy proteins in 2c induced HT-29 cells. Cells were treated with 2c (14.9 μM for 12, 24, 48 h) and expression levels of
Beclin-1, Atg 3, Atg 5, Atg 7, Atg 5-Atg 12, p62 were quantified by western blot analysis from cell lysates of control and treated cells. Analysis was
confirmed with three different sets of experiments. β-actin served as a loading control
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To substantiate whether Beclin1, the central protein of
autophagic pathway expressed in HT-29 cells after 2c
treatment for 12 and 24 h with respect to control we la-
beled Beclin1 with red and nucleus with blue fluorescence
(DAPI). Immunofluorescence in HT-29 cells revealed that
gradual increase of expression level of autophagy regu-
lated protein in compared with corresponding control
(Fig. 11a). Furthermore, we similarly analysed the expres-
sion levels of Atg5, Atg7 (Fig. 11b, c) and found enhanced
level of protein expression with progression of time. We
next sought to determine p62, an adaptor protein was
labeled with red fluorescence and nucleus was counter-
stained with DAPI for 24 h. The adaptor protein p62 rec-
ognizes ubiquitinylated proteins during autophagy by its
ubiquitin receptors interacting with ubiquitin noncova-
lently via their ubiquitin-binding domains. This p62 can
deliver ubiquitinylated cargos to autophagolysosome for
their degradation and is required for the aggregation of
ubiquitinylated proteins. Furthermore, p62 itself is grad-
ually eliminated with autophagic clearance [37]. As p62
plays essential roles in cellular ubiquitinylated proteins
clearance and levels of p62 usually inversely correlate with
Fig. 5 Conversion of LC3A to LC3B and densitometric analysis. a Control and 2c treated (14.9 μM; 0–48 h) whole cell lysates of HT-29 cells were
prepared and analysed by western blotting to study the conversion of LC3A to LC3B. β-actin was used as loading control. The figure is a representative
profile of at least three experiments. b Bands obtained from western blotting were quantified by densitometric analysis and expression level of LC3
protein was determined. Histograms represent LC3 protein expression normalized to β-actin (***p <0.001)
Fig. 6 Effect of autophagy inhibitor 3-MA in 2c induced cytotoxicity.
HT-29 cells (2.5 × 104/100 μl of RPMI 1640 medium / well) were
pre-treated with autophagy inhibitor, 3-MA (10 mM) for 4 h followed
by 2c treatment for 48 h. Cell viability was measured by MTT assay.
Histograms represent percentage cell viability (Mean ± SEM) obtained
at the IC50 concentration of 2c (14.9 μM) and has been derived from at
least three experiments in duplicate (***p <0.001 compared to only 2c
treated cells)
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autophagic degradation, we monitored p62 expression level
for 12, 24 and 48 h (Fig. 11d) as confirming evidence to-
wards progression of autophagy. As shown in Fig. 11d, p62
expression level was found to have gradually decreased with
progression of 2c treatment time in HT-29 cells.
Conjointly all the stages of autophagy from formation of
autophagosome to its fusion with lysosomes can be moni-
tored with expression level of LC3B protein at different
time point. Upon activation of autophagy, pro-LC3 is
cleaved at its C-terminus to form LC3A and the free C-
terminal glycine is then modified by lipidation to a faster
migrating form, LC3B which is tightly associated with the
autophagosomal membrane via conjugation to phosphati-
dylethanolamine [38]. Expression level of LC3B is directly
correlate with progression of autophagy. We next per-
formed immunofluorescence analysis for LC3B, expression
level of which was found to increase in a time dependent
manner (Fig. 11e). Furthermore, we studied the influence
of analogue 2c on autophagy component which is playing
key role in autophagy pathway like LAMP-1 (green)-LC3B
(red); LC3B (green)-Lysosome (Lysotracker, red) and p62
(green)-LC3B (red)-DAPI (blue) by colocalization Finally
as we have already shown proteasomal degradation path-
way downregulated after 2c treatment so autolysosomal
pathway may be the only system available for ubiquitiny-
lated proteins degradation. The adaptor molecule, p62 de-
livers the ubiquitinylated cargos to autolysosome for
degradation. So, colocalization of Ubiquitin (green)-Lyso-
some (Lysotracker, red) and p62 (green)-lysosome (Lyso-
tracker, red) were studied to confirm whether protein
degradation in autophagy induced HT-29 cells followed
autolysosomal pathway (Fig. 12a, b, c).
As we know LC3B protein present on autophagosomes
which ultimately fuses with lysosome so we stained LC3B
with green fluorescence and lysosome with lysotracker red
and found 75.2 % of their colocalization after 24 h of 2c
treatment whereas no LC3B expression was observed in
case of control HT-29 cells (Fig. 12a, b, d). We next colo-
calize p62 (green) with Lysosome (Lysotracker, red) as p62
cargos polyubiquitinated proteins to autolysosome for
degradation. p62 was colocalized with lysosome by 69.6 %
after 24 h of 2c treatment but no significant colocalization
was noticed in untreated cells (Fig. 12a, b, d). Furthermore
we interested to manifest this phenomenon by colocaliza-
tion of ubiquitin (green) with lysosome (Lysotracker, red)
as proteins which are destined for degrdation in autolyso-
some by p62 are all tagged with ubiquitin chain and in
control cells ubiquitin expression was low but in 2c treated
HT-29 cells 79.8 % of their colocalization of ubiquitin with
lysosome was observed (Fig. 12a, b, d). Finally, we again
focused on p62 which possesses a C-terminal ubiquitin-
binding domain (UBA) [39] and a short LIR (LC3-interact-
ing region) sequence responsible for LC3 interaction. p62
Fig. 7 Effect of Bafilomycin A1, Chloroquine, E64d+PepstatinA. HT-29 cells were pre-incubated with Bafilomycin A1(50 nM), Chloroquine (5 μM)
and E64d+PepstatinA (10 μg/ml) for 4 h and then treated with 2c (14.9 μM; 48 h). After preparation of whole cell lysates, western blotting was
done using specific antibodies against LC3B. Analysis was confirmed with three different sets of experiments
Fig. 8 2c-induced expression of Beclin1 and LC3B mRNA. 2c treated
and untreated HT-29 cells were subjected to RNA isolation and the
expression of mRNA was analysed. Beclin1 and LC3B expression in
HT-29 cells treated with or without 2c were measured by qRT-PCR
and normalized to GAPDH expression. Data are expressed as fold
change relative to untreated cells showing induction of autophagy
in cells treated with 2c for different time intervals (12, 24 and 48 h)
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serves as a linker in between LC3B on autolysosome and
ubiquinated substrate. So, we were interested to check per-
centage of colocalization of p62 (green) with LC3B (red) as
well as counterstained nucleus with DAPI (blue) and found
87.1 % of colocalization in 2c treated HT-29 cells (12b, c).
LC3B expression was found negligible in control cells as
autophagy was not induced in on the contrary p62 was
significantly expressed (Fig. 12a). Lysosomal-associated
membrane protein-1 (LAMP-1), the main constituent of
lysosomal membrane, was measured to ensure autophago-
lysosome formation and assessed colocalization of LAMP-
1 (green) with LC3B (red). No LC3B expression was found
in control cells whereas 75.9 % of colocalization was ob-
tained in 2c treated HT-29 cells after 24 h of treatment
(Fig. 12a, b, d).
So, our findings suggest that protein degradation in
autophagy induced HT-29 cells follows autolysosomal
pathway and all polyubiquitinated proteins are reached
to autolysosome by p62 for their degradation.
2c Causes independent occurrence of apoptosis and
autophagy in HT-29 cells
Previously, 2c was found to induce apoptosis and all
findings of this present study revealed 2c as an inducer
of autophagy in HT-29 cells. Consequently, crosstalking
in these two signaling cascade was studied. The interplay
between autophagy and apoptosis is complicated and dif-
fers with cell types and specific stress causing factors of
cell death [40]. They may act independently to each other.
To determine whether 2c induced apoptosis and autoph-
agy in HT-29 cells are independent or interconnected, we
evaluated cells treated with 2c in the presence of either
apoptosis or autophagy inhibitors (Z-VAD-FMK and 3-
MA respectively). After treatment with 3-MA (10 mM) for
4 h, cells were incubated with 2c (14.9 μM; 48 h) followed
by western blot analysis. Figure 13 revealed that in pres-
ence of autophagy inhibitor and 2c treatment, Bax, a well
known proapoptotic protein level remained same as com-
parable to that of cells treated only with 2c. Similarly, cell
lysates were pre-incubated with Z-VAD-FMK (20 mM;
4 h) followed by treatment with 2c and analyzed for con-
version of LC3A to LC3B, molecular marker for autophagy.
Figure 13 suggests that in presence of apoptosis inhibitor,
Z-VAD-FMK there was no significant changes observed in
LC3B conversion in comparison to cells treated only with
2c. Our result suggests that apoptosis and autophagy occur
independently to each other in 2c induced cytotoxicity.
Discussion
Autophagy is a catabolic degradation process by its name
(self eating) and mainly required to maintain cellular
homeostasis. Autophagy constitutes multiple steps. It starts
Fig. 9 TEM microphotographs of 2c treated HT-29 cells. Ultra structure of control and 2c (14.9 μM; 12, 24, 48 h) treated HT-29 cells shows formation of
double membrane autophagic vacuoles. The figure is a representative profile of at least three experiments
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Fig. 10 (See legend on next page.)
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with formation of double membrane vesicles followed by
engulfment of damaged proteins and organelles and then
fusion of cargo-loaded autophagosomes with lysosomes
which causes formation of autophagolysosomes in which
the engulfed contents are broken down by acidic lysosomal
hydrolases. Autophagy may play a dual role according to
cellular environmental needs to contribute to cell survival
and at the same time sometimes for cell death [41].
Nowadays increasing number of studies proposes au-
tophagic cell death as a mechanism of action of some anti-
cancer agents. These investigations suggest that autophagic
cell death induction in cancers may have a therapeutic
value. D Gozuacik et al. [42] remarked that molecules
which are capable of inducing both autophagic cell death
and apoptosis as ‘golden bullet’ since they are capable
of triggering both caspase-dependent and autophagic,
caspase-independent cell death at the same time. In this
context, as we have previously reported that betulinic acid
analogue, 2c is capable to induce mitochondria dependent
pathway of apoptosis [43] and further we targeted to study
another mode of cell death, autophagy which is one of the
important constituent of cellular catabolic system. In
(See figure on previous page.)
Fig. 10 2c treatment causes declination of Proteasome degradation pathway. HT-29 cells were treated with 2c and then subjected to measure three
subtypes of proteasomal activities. As shown in figure there is a gradual time dependent decrease in the proteasomal activities i.e. downregulation of
(a) chymotrypsin-like, (b) trypsin-like and (c) caspase-like enzyme activities occurs with respect to control according to different time intervals (12, 24,
48 h). Values are mean ± S.D and represent at least three experiments (**P <0.05 compared to control)
Fig. 11 Timecourse analysis of different autophagic proteins expression with immunostaining. Representative Confocal Laser Scanning
Microscopy (CLSM) images showing HT-29 cells were treated with 2c for autophagic component like Beclin-1(12 and 24 h), Atg-5(12 and 24 h),
Atg-7(12 and 24 h), p62(12, 24, 48 h) and LC3B(12, 24, 48 h) fixed and stained with respective fluorescent tagged secondary antibody of (a)Beclin1
(red), (b) Atg5 (red), (c) Atg7 (red), (d) p62 (red) (e) LC3B (red) and counter stained with DAPI (blue). Graphs depict quantification of intensity of
Beclin1, Atg5, Atg7, LC3B and p62 expression level respectively in HT-29 cells at indicated time points after 2c incubation. Values are expressed as
Mean Fluorescence Intensity ± SEM of three independent experiments (**p <0.01, ***p <0.001). Scale bars, 10 mm
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addition, we focused on proteasomal degradation pathway
also to investigate whole catabolic pathway after explor-
ation of 2c on HT-29 cells. To the best of our knowledge,
this is the first report which shows that a betulinic acid
analogue has potential to induce autophagy in human
colon carcinoma cells. In current cancer research the ut-
most requirement of successful cancer therapies demand
development of drug without cytotoxicity to normal cells.
Initially we screened 2c on various cancer cells and nor-
mal human PBMC. Analogue 2c was found most effective
to selectively kill human colon carcinoma HT-29 cells
with IC50 14.9 μM and with negligible effect on normal
human PBMC [43].
We directly perceived the percentage of autophagosome
formation using Cyto-ID Green probes by flow cytometry
and found an increasing percentage of autophagosome
formation in 2c treated HT-29 cells in a time dependent
manner (Fig. 1).
Earlier reports suggest that formation of autophagic
vacuoles is an established marker of ‘autophagic cell
death’ [44]. As we have shown in Fig. 2, Acrilidine Or-
ange stains autophagic acidic vacuoles and emits red
fluorescence after treatment with 2c for different time
periods.
Moreover, we have validated progression of autophagy
pathway by using Monodansylcadaverine (MDC), an auto-
fluorescent compound which is reported to stain autopha-
gic vacuoles. As shown in Fig. 3, analogue 2c treated HT-29
cells showed. a subtle increase in accumulation of MDC-
labeled vacuoles.
We have endeavoured to measure different autophagy
related protein induced by 2c in HT-29 cells like Beclin-1,
a key regulatory protein of autophagy involved in nucle-
ation step of autophagosome formation. Autophagy-related
gene (Atg) products are another important regulator of
autophagosome formation. Autophagy initiation is accom-
panied by amalgamation of Atg 12 to Atg 5 with the aid of
Atg 7. We observed that 2c was capable to increase expres-
sion levels of Beclin-1, Atg 3, Atg 5, Atg 7, coalesced form
Atg 5-Atg 12 and p62 (Fig. 4) as well as convertion of
LC3A to LC3B (Fig. 5), the gold standard hallmark of au-
tophagy [45] which were measure by western blot analysis.
Cytosolic-associated protein light chain 3 (LC3A) remains
conjugated with phosphatidylethanolamine [46]. In pres-
ence of Atg 3, LC3A is converted to the membrane bound
lipidated form, LC3B.
To determine the contribution of 2c in induction of
autophagic mode of cell death in HT-29 cells, 3-MA
(interferes with autophagy initiation) was used. Inter-
estingly, 3-MA was found to retrieve the viability of 2c
treated HT-29 cells (Fig. 6). Autophagic flux can be moni-
tored by LC3B turnover using western blot analysis in the
presence and absence of lysosomal degradation inhibitors,
such as pepstatin A, E64d, bafilomycin A1, chloroquine
etc. [47]. It is reported that the level of LC3B is in-
creased in the presence of the lysosomal degradation
inhibitors because the degradation of LC3B through the
autophagic pathway was hindered. In our study we
demonstrated that LC3B level increased in the presence
of each lysosomal degradation inhibitors in compare to
Fig. 12 Co-localization of proteins associated with autophagy. Immunofluorescence (IF) demonstrates (a) colocalization of LC3B (green) with
Lysosome (red), p62 (green) with Lysosome (red), Ubiquitin (green) with Lysosome (red), LAMP-1(green) with LC3B (red) and p62 (green) with LC3B
(red) in HT-29 cells without 2c treatment. b colocalization of LC3B (green) with Lysosome (red), p62 (green) with Lysosome (red), Ubiquitin (green)
with Lysosome (red), LAMP-1(green) with LC3B (red) and (c) p62 (green) with LC3B (red) counterstained with DAPI (blue) in HT-29 cells treated with
2c for 24 h. d percentage of cellular puncta co-localized for five pair of protein sets were determined. Scale bars, 10 mm. The bars
represent Mean ± SEM
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control suggesting 2c is capable to induce autophagy in
HT-29 cells (Fig. 7).
We have also shown time dependent up-regulation of
Beclin-1 and LC3B mRNA expression level (Fig. 8).
Literatures suggest that detecting the presence of autoph-
agic vesicles by using transmission electron microscopy
(TEM) is the most sensitive and gold standard technique to
monitor autophagy. Autophagosomes are typically identi-
fied as double membrane envelop vacuolar structures, se-
questering cellular contents [48]. Our TEM data suggest
that treatment with analogue 2c in HT-29 cells causes
formation of double membrane autophagic vacuoles consti-
tutively after 12, 24 and 48 h of treatment as compared to
control HT-29 cells (Fig. 9). At 12 h of treatment few
autophagosomes were seen but transient increase in the
number of autophagosomes was noted after 24 and 48 h of
2c treatment in HT-29 cells. These membrane enclosed au-
tophagic vacuoles become enlarged and eventually forms
giant double membrane autophagosomes which finally
fused with lysosomes resulting in the formation of autolyso-
somes. As we can see from the figure autophagosomes be-
come enlarged at 24 h and at 48 h autolysosome formation
was completed.
In our study we have also observed downregulation of
caspase-like, trypsin like and chymotrypsin-like activities
of the proteasomal enzyme after analogue 2c treatment
(Fig. 10).
In support of the notion of altered expression of different
autophagic proteins by western blotting, we also observed
time dependent protein expression levels of Beclin-1, Atg
5, Atg 7, LC3B and p62 by immunoflourescence study
using confocal microscopy (Fig. 11). Upon formation of
LC3B, it continues to exist on mature autophagosomes till
the complete association of autophagosomes with lyso-
somes. We aimed to investigate the colocalization of LC3B
with lysosome. After 24 h treatment with 2c, cellular
Fig. 13 Effect of 3-MA and Z-VAD-FMK on apoptosis and autophagy. HT-29 cells were incubated with IC50 concentration of 2c (48 h) after treatment
with 3-MA (10 mM; 4 h) or Z-VAD-FMK (20 mM; 4 h) as well as untreated cells also. (a) Cell viability was measured after Z-VAD-FMK (20 mM, 4 h) treat-
ment. (b) Whole cell lysates were prepared and subjected to immunoblot analysis using specific antibodies against Bax or LC3. Analysis was confirmed
with three different sets of experiments
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puncta which were positive for both red and green (merged
image) were found in HT-29 cells (Fig. 12a).
Concurrently, p62 protein is considered as an adaptor
molecule which contains dual binding site through
which it can simultaneously interact with both LC3B as
well as polyubiquitinated protein aggregates. p62 is
usually degraded during autophagy as it is involved in
trafficking of cellular ubiquitinated proteins to the pro-
teasome or to autophagolysosome. We subsequently fo-
cused to investigate whether the adaptor molecule p62
is engaged in trafficking cellular ubiquitinated proteins
to autophagolysosome.
In our study we observed that autophagy is crucially re-
lated with proteasomal degradation pathway which inspired
us to find out 2c mediated interplay between autophagy
and proteasomal degradation pathway through involvement
of the ubiquitinated protein adapter molecule, p62. Emer-
ging evidence indicates that proteasome dependent protein
degradation was downregulated upon activation of au-
tophagy which makes completion of polyubiquitinated
proteins degradation via formation of autolysosome [49].
It is reported that the ubiquitin binding protein p62 which
contain a ubiquitin-binding domain, can cargo the polyu-
biquitinated proteins to autolysosome [50]. In this milieu,
we studied the co-localization of LAMP-1 with LC3B,
LC3B with Lysosome, p62 with lysosome, ubiquitin with
lysosome and LC3B with p62. We determined the per-
centage of cellular puncta co-localized for all five pairs of
protein sets which indicated progression of autophagic
pathway and clearance of cellular ubiquitinated proteins
through formation of autophagolysosome (Fig. 12a, b).
In this study, our objective was to unveil the molecular
mechanism towards betulinic acid analogue (2c) induced
cell death in colon cancer cell. In view of the high po-
tency of betulinic acid towards colon cancer, this com-
pound has the potential to be exploited as a therapeutic
agent in the adjunct therapy of colorectal cancer.
Conclusions
On the basis of our present study we must state that our
lead compound 2c, a potent betulinic acid analogue in-
duces autophagy in human colon carcinoma, HT-29 cells
at the same time averts proteasomal degradation path-
way in parallel suggesting a novel crosstalk in between
these two pathways. Recent studies have also shown that
a regulation exists between the UPS and autophagy, the
two cellular catabolic systems. We have already reported
that 2c induces apoptosis in HT-29 cells in our previous
study. So, all together our findings unveil that 2c is cap-
able to induce both apoptotic as well as autophagic mode
of cell death in HT-29 cells independently. Interestingly,
as 2c causes significant reduction in cell viability of both
the colorectal adenocarcinoma cell lines (HT-29 and
HCT-15), so it may prove itself to be a potential
therapeutic agent for colon cancer, providing a basis for
the development of the compound as a novel anticancer
agent.
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